Menu
TMC Life Sciences Berhad (TMCLS) is one of the fastest growing healthcare groups in Malaysia. It has been listed on the Main Market of Bursa Malaysia Securities Berhad since 2005. The Group aims to be the “Pan-Asia Preferred Healthcare System of Choice” delivering quality, value-based care to its patients and customers. TMCLS has embarked on a major expansion plan, with significant additional capacity and capabilities projected to come on stream by year 2020.
The plan includes the expansion of its flagship hospital, Thomson Hospital Kota Damansara to a 600-bed hospital with additional specialist centres, operating theatre, a Cancer Centre and a multi-storey carpark. A new integrated medical hub – Thomson Iskandar – will be developed in the proposed Vantage Bay Healthcare City in bustling Johor Bahru. Located just off the Causeway linking Johor and Singapore, Thomson Iskandar will house a 500-bed tertiary hospital, specialist medical suites and related health and wellness facilities.
To provide exceptional medical services and compassionate care to our patients and patrons through continous effort, dedication, commitment and the application of world class standards in all of our endeavours.
To be the premier provider of outstanding value-based medical services in South East Asia.
Previous
Next
Thomson Hospital Kota Damansara
TMC Fertility Centre
© 2019 All rights reserved.
TMC Life Sciences Berhad Co. No.: 200301021989 (624409-A)
Aged 71, Malaysian
Non-Independent Non-Executive Chairman
Professor Emeritus Dato’ Dr. Khalid Bin Abdul Kadir was appointed to the Board on 7 October 2004. He graduated with first-class honours in B.Med. Sc. (1973) and a first class honours in MBBS from Monash University, Australia in 1975 and PhD in 1982. He was awarded the FRACP (Australia) and FRCP’s from Edinburgh, Glasgow, Ireland and London and the Honorary Fellowship of the American College of Physician in June 2008 and is a Fellow of the Academy of Science Malaysia.
Professor Emeritus Dato’ Dr. Khalid started his career as a lecturer at Universiti Kebangsaan Malaysia (“UKM”) in 1982, promoted to Associate Professor in 1984, Head of Department of Medicine in 1985, Dean of the Medical Faculty and Professor in 1990. In 1997-2000, he was Director of the new Hospital Universiti Kebangsaan Malaysia (“HUKM”) with the task of building up HUKM. Upon his retirement in 2004, he was awarded the title of Professor Emeritus.
He then joined Monash University as Professor of Medicine and started the Tan Sri Jeffery Cheah Clinical School in Johor.
He was one of the pioneers of the Company and Thomson Hospitals (formerly known as Tropicana Medical Centre) and is currently the consultant Endocrinologist.
He was in the Malaysia Medical Council from 1986 to 2001, President of the Persatuan Diabetes Malaysia from 1985 to 1990, President of the Malaysia Endocrine Society from 1995 to 2001, Member of Council, International Diabetes Federation from 2001 to 2002, and Master of The Academy of Medicine of Malaysia from 2006 to 2008.
He is active in research and has published more than 310 papers in international and national peer reviewed journals. Professor Emeritus Dato’ Dr. Khalid Bin Abdul Kadir was conferred The National Science Award in 1997, The Asia Pacific Nutrition Award in 1996 and The Merdeka Award in 2008, and delivered The Tunku Abdul Rahman Oration, Academy Medicine Malaysia 2010, and the Gold Medal for outstanding services to Malaysian Medical Association May 2016.
Professor Emeritus Dato’ Dr. Khalid Bin Abdul Kadir has no family relationship with any Director and/or major shareholder of the Company. He has no convictions of any offences within the past five (5) years and has no public sanctions and/or penalties imposed by the relevant regulatory bodies during the financial year. He has no conflict of interest with the Company. He does not hold any directorship in other public companies and listed issuers in Malaysia.